Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ImmunityBio (IBRX) Other Operating Expenses: 2014-2025

Historic Other Operating Expenses for ImmunityBio (IBRX) over the last 1 years, with Sep 2025 value amounting to $177,000.

  • ImmunityBio's Other Operating Expenses was N/A to $177,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $886,000 for FY2023, which is 30.10% up from last year.
  • According to the latest figures from Q3 2025, ImmunityBio's Other Operating Expenses is $177,000, which was up 30.15% from $136,000 recorded in Q2 2025.
  • ImmunityBio's 5-year Other Operating Expenses high stood at $886,000 for Q4 2023, and its period low was $58,000 during Q1 2025.
  • Moreover, its 2-year median value for Other Operating Expenses was $156,500 (2025), whereas its average is $314,250.
  • Data for ImmunityBio's Other Operating Expenses shows a peak YoY surged of 30.10% (in 2023) over the last 5 years.
  • Over the past 3 years, ImmunityBio's Other Operating Expenses (Quarterly) stood at $681,000 in 2022, then spiked by 30.10% to $886,000 in 2023, then reached $177,000 in 2025.
  • Its Other Operating Expenses was $177,000 in Q3 2025, compared to $136,000 in Q2 2025 and $58,000 in Q1 2025.